senior notes offering Thermo Fisher Scientific Prices $2.95B Senior Notes Offering The proceeds from the offering will be used to redeem previous senior notes due 2023 and 2024 and for general corporate purposes. Exact Sciences to Net $133M in Senior Notes Exchange and Purchase Agreement The company has agreed to exchange convertible senior notes due 2027 and 2028 for $500 million in new notes due 2023. Thermo Fisher Scientific Prices $1.2B and €1.25B Senior Note Offerings The firm said the proceeds will be used for general corporate purposes, possibly including the acquisition of companies or businesses and repayment of debt. Thermo Fisher Scientific Prices ¥109.5B Senior Note Offering The firm said the proceeds will be used for general corporate purposes, possibly including the acquisition of companies or businesses and repayment of debt. Bio-Rad Laboratories Closes $1.2B Senior Notes Offering The firm said the proceeds will be used for general corporate purposes, including potentially the acquisition of other companies, products, or technologies. Dec 2, 2021 Danaher Prices $1B Offering of Senior Notes Nov 9, 2021 Thermo Fisher Scientific Prices €2.8B Senior Notes Offering Oct 20, 2021 Thermo Fisher Scientific Prices $5.85B Senior Notes Offering Oct 7, 2021 Thermo Fisher Scientific Prices €5.25B Notes Offering Sep 9, 2021 PerkinElmer Prices Senior Notes Offering Aug 10, 2021 Thermo Fisher Scientific Prices $3.1B Senior Notes Offering May 12, 2021 Sequencing Startup Singular Genomics Files for $100M IPO Mar 18, 2021 Illumina Prices $1B Senior Notes Offering Mar 4, 2021 PerkinElmer to Offer $800M in Senior Notes Mar 4, 2021 Agilent Prices $850M Senior Notes Offering Feb 10, 2021 Pacific Biosciences to Obtain $900M Investment From SoftBank Subsidiary Dec 3, 2020 Progenity Prices Separate Public Stock, Private Senior Notes Offerings Dec 1, 2020 Progenity to Raise $100M in Separate Public Stock, Private Senior Notes Offerings Nov 17, 2020 Guardant Health Prices $1B Senior Notes Offering Sep 30, 2020 Danaher Prices $1B Senior Notes Offering Sep 28, 2020 Hologic Completes $950M Senior Notes Offering Sep 15, 2020 Hologic Prices $950M Offering of Senior Notes Sep 14, 2020 Hologic Gets WHO Prequalification Approval for HIV Assay, Offers $950M in Senior Notes Jun 2, 2020 Agilent to Raise $500M Through Senior Notes Offering May 8, 2020 Luminex Prices $260M Senior Notes Offering Load More Breaking News NanoString, A*Star, Next Level Genomics to Launch Spatial Biology Laboratory in Singapore FDA Approves Entrogen's RAS Mutation Detection Kit as CDx for Vectibix Cancer Predisposition Variants Increase Secondary Cancer Mortality Risk in Pediatric Survivors BostonGene, Johns Hopkins University Partner for Multiple Cancer Clinical Research Projects KromaTid, Noble Life Sciences Ink Distribution, OEM Agreement The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.